Dashboard

Below is the reformatted clinical note based solely on the provided information:

Patient Information

• Patient Name: Alicia Blanks
• Patient Gender: Female
• Date of Service: November 19, 2024
• Provider Name: Michael McDowell
• Provider Specialty Code: 394800008
• Place of Service: Office (11)
• Visit Type: Established Patient
• Telehealth: No

Chief Complaint

Follow-up appointment for attention/ADHD medication management and sleep concerns.

History of Present Illness (HPI)

• Presenting Concerns:

  • Follow-up regarding attention/concentration issues and sleep difficulties.

• Details Related to Attention:

  • Patient reports significant improvement in attention span with the current medication regimen, commenting that “the meds have helped a ton.”

• Sleep Concerns:

  • The patient reports difficulty with sleep maintenance, experiencing awakenings approximately every hour throughout the night.
  • No difficulty with sleep onset as she can fall asleep easily.
  • Describes frequent, vivid dreaming where she feels as though she has “lived a life” during her brief sleep intervals, yet perceives minimal elapsed time.
  • Expresses uncertainty about whether she is achieving REM sleep.

• Additional Symptoms:

  • Appetite: Reduced appetite; however, the patient does not view it as problematic, noting she may go through the day without eating much while maintaining hydration (“drinks a ton of water”).
  • Psychosocial Stressors:
    • Significant workplace stress involving conflict with a difficult coworker.
    • Reports being emotionally strained by ongoing conflicts, though mentions some recent improvement with executive support.
    • Acknowledges personal tendencies of over-helping others and is learning to set boundaries.
    • Currently in therapy with Ms. Boozman, which she finds beneficial.

Note: Specific onset, location, duration, and severity details are not explicitly provided.

Past Medical History (PMH)

• Not provided in the documentation.

Review of Systems (ROS)

• Not explicitly detailed in the provided notes.

Physical Examination

Mental Status Examination:

• Appearance: Not formally documented; patient was appropriately engaged.
• Behavior: Cooperative and engaged in discussion.
• Speech: Normal rate and rhythm, with occasional coughing/throat clearing during the session.
• Mood: Described as affected by stressors yet buoyed by some positive developments.
• Affect: Appropriate to the topics discussed; patient was able to laugh and engage casually.
• Thought Process: Linear and goal-directed.
• Thought Content: Centered around workplace stressors, sleep issues, and medication management. No suicidal or homicidal ideation noted.
• Cognition: Alert and oriented; patient reports improved attention in correlation with current medication.

Laboratory/Testing:

• Pharmacogenomic Testing:
  • Findings indicate the patient does not metabolize “FODAC” (folic acid) appropriately.
  • Discussion occurred regarding the relationship to L-methylfolate supplementation.
  • The patient reports having L-methylfolate at home.

Vital signs and other physical exam components were not documented.

Assessment / Diagnosis

1. Attention Deficit Disorder

   • Clinical impression: Stable/Improved on the current medication regimen.
   • Reasoning: Significant reported improvement in attention span and concentration.

2. Sleep Maintenance Insomnia

   • Clinical impression: Persistent sleep maintenance difficulties.
   • Reasoning: Patient reports waking approximately every hour with vivid dreams.

3. Occupational Stress

   • Clinical impression: Significant workplace-related stress contributing to emotional strain.
   • Reasoning: Ongoing conflict and recent executive intervention, with supportive therapy ongoing.

4. Folic Acid Metabolism Abnormality

   • Clinical impression: Abnormal metabolism of folic acid as confirmed by pharmacogenomic testing.
   • Reasoning: Discussion regarding the necessity for B vitamin supplementation given the test results.

5. OCD Screening

   • Clinical impression: Subclinical findings.
   • Reasoning: Total OCD score is 0/40 with no obsessive or compulsive symptoms reported.

Plan / Treatment

1. Medication Management:

   • Continue current ADHD medication (refills provided).
   • Initiate Escitalopram (Lexapro) 10 mg:
     • Instructions: Take at bedtime to assist with sleep and potential anxiety.
     • Provider advised that if sleep disruption occurs (rare), consider switching to daytime dosing.

2. Supplementation:

   • B Vitamin Supplementation:
     • Recommendation: Incorporate B12 and/or B vitamin supplementation given pharmacogenomic findings and high stress levels.
     • Note: Patient to supplement alongside L-methylfolate already at home.

3. Lifestyle Recommendations:

   • Hydration:
     • Continue adequate water intake, especially given decreased appetite and dry indoor heating conditions.

4. Therapy:

   • Continue ongoing therapy with Ms. Boozman for psychosocial support.

5. Follow-Up:

   • A follow-up appointment is scheduled for December 10, 2024, at 2:00 PM (approximately 3 weeks) to assess the response to Lexapro.

6. Patient Education:

   • Discussed trazodone as an alternative sleep aid option (non-habit forming, 50 mg dosing) if needed in the future, with explanation regarding its mechanism and potential for morning grogginess.

7. Prescriptions Sent:

   • Escitalopram 10 mg (Take at bedtime)
   • Refills for current ADHD medication

Additional Documentation

• Informed Consent / Risk Assessment:

  • Not explicitly documented in the provided notes.

• Signature/Date:

  • The note includes the date of service (11/19/2024); provider signature is assumed as part of the documentation process.

Quality Grade

Quality Grade: High

Additional Questions for Improvement

• Would additional details regarding the patient’s Past Medical History (PMH) and Review of Systems (ROS) enhance the overall clinical context?
• Are there any specific physical examination details or vital signs that should be included in future documentation?
• Is further clarification needed on the duration and onset of sleep difficulties or attention issues to improve clinical clarity?